Arcus Biosciences, Inc.
RCUS · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $150,000 | $127,000 | $206,000 | $147,914 |
| Short-Term Investments | $828,000 | $632,000 | $803,000 | $351,394 |
| Receivables | $25,000 | $42,000 | $43,000 | $746,822 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $13,000 | $30,000 | $14,000 | $15,620 |
| Total Curr. Assets | $1,016,000 | $831,000 | $1,066,000 | $1,261,750 |
| Property Plant & Equip (Net) | $47,000 | $51,000 | $135,000 | $137,423 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $14,000 | $107,000 | $134,000 | $184,995 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $73,000 | $106,000 | $10,000 | $7,730 |
| Total NC Assets | $134,000 | $264,000 | $279,000 | $330,148 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,150,000 | $1,095,000 | $1,345,000 | $1,591,898 |
| Liabilities | – | – | – | – |
| Payables | $18,000 | $17,000 | $20,000 | $10,261 |
| Short-Term Debt | $12,000 | $11,000 | $3,000 | $5,100 |
| Tax Payable | $1,000 | $0 | $0 | $1,815 |
| Deferred Revenue | $85,000 | $91,000 | $97,000 | $102,003 |
| Other Curr. Liab. | $110,000 | $65,000 | $73,000 | $46,905 |
| Total Curr. Liab. | $226,000 | $184,000 | $193,000 | $166,084 |
| LT Debt | $48,000 | $0 | $117,000 | $116,887 |
| Deferred Rev, NC | $234,000 | $307,000 | $355,000 | $462,217 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $157,000 | $142,000 | $23,000 | $5,260 |
| Total NC Liab. | $439,000 | $449,000 | $495,000 | $584,364 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $12,000 | $11,000 | $117,000 | $116,887 |
| Total Liabilities | $665,000 | $633,000 | $688,000 | $750,448 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1,617,000 | $1,311,000 | $1,206,000 | $7 |
| Retained Earnings | -$1,132,000 | -$849,000 | -$542,000 | -$275,354 |
| AOCI | $0 | $0 | -$7,000 | -$1,261 |
| Other Equity | $0 | $0 | $0 | $1,118,058 |
| Total Equity | $485,000 | $462,000 | $657,000 | $841,450 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,150,000 | $1,095,000 | $1,345,000 | $1,591,898 |
| Net Debt | -$90,000 | -$116,000 | -$86,000 | -$25,927 |